Adaptive therapy treatment for ovarian cancer patients
Barts Charity has awarded nearly £500,000 to investigate adaptive therapy, a personalised approach to ovarian cancer treatment 
Ovarian cancer diagnosis

Barts Charity has awarded Dr Michelle Lockley of Barts Cancer Institute, Queen Mary University of London, nearly £500,000 to investigate adaptive therapy, a new personalised treatment approach for ovarian cancer. 

On average, 7,500 women in the UK are diagnosed with ovarian cancer each year, one of the most common types of cancer in women. The earlier ovarian cancer is diagnosed and treated, the better the chance of a cure. But often it’s not recognised until it’s already spread and a cure is not possible. While ovarian cancer survival is improving, far too many women still lose their lives within 10 years of diagnosis.  

Adaptive therapy – a new treatment approach

The treatment approach, called adaptive therapy for ovarian cancer will benefit 3,000 patients annually over the next three years. 

“This strategy could transform cancer care: patients would receive fewer drugs, less often, and live longer with fewer treatment-related side effects,” says Dr Lockley. “The research aims to address the unmet need of therapy resistance. To maximise future public health gains, it is crucial that we learn from the patients that participate in this study.” 

Adaptive therapy (AT) is a novel, personalised treatment strategy in which drug doses are tailored for individual patients to prevent drug resistance. Drug-resistant cancer cells usually grow more slowly than their drug-sensitive counterparts and this clinical trial plans to exploit this Achilles’ heel by prescribing periods without drugs. 

This strategy could transform cancer care: patients would receive fewer drugs, less often, and live longer with fewer treatment-related side effects

Dr Michelle Lockley

Honorary Consultant Oncologist at Barts Cancer Institute
Clinical trial for UK cancer patients

This is the first adaptive therapy clinical trial for UK cancer patients and the first global experience testing adaptive therapy in high grade serous ovarian cancer (HGSOC), which is among the most fatal forms of all cancers.  

This unique clinical trial approach may lead to more effective personalised treatments for patients with ovarian cancer, with the hope of extending patient survival. Dr Lockley says, “The unifying evolutionary principles we reveal could completely redefine the administration of diverse therapies in multiple cancer types.” 

Clinical experience shows that when cancers relapse, repeated treatment with the same therapy is less effective. Adaptive therapy could significantly benefit patients by prolonging drug-sensitivity and extending tumour control, while at the same time, reducing chemotherapy dose and drug-induced toxicity.  

The discoveries here will be generalisable and have the potential to radically redefine anti-cancer therapy and improve survival of patients receiving treatment for multiple cancer types. 

You might also like

2016, TAG Heuer Marking Heuer Aquaracer collection Reloaded, launched a new Aquaracer Aquaracer timepieces, to further enhance their natural overall richard mille replica performance and design. Scenario extended from the earlier 41-43 mm. Clay bezel re-designed etched sterling silver coloring stats, its date window zoomed present (re-introduced recently, to adhere to this season), preparing the actual sophisticated persona. The new situation is equipped Calibre A few Programmed activity, for your watch provides established reliability.

Royal Parks Half Marathon - Charity place registration

Thank you for registering for one of our charity places – and welcome to the Barts Charity team!

By submitting this form you are agreeing for us to contact you with race-day information, training and fundraising tips in relation to the Royal Parks Half Marathon 2022. This may include email, phone call or text message. You can of course update your preferences at any time, and we will fully respect your wishes (see below for more information).

Application information

*¹Please note we will do our best to match your wishes to the most relevant fund, but we cannot guarantee that sponsorship will be used to fund specific items

We may take photos on the day at the event, which could be used in Barts Charity communications and marketing activity, including but not limited to our website, social media, digital or printed materials, and press. If you are not happy for your image to be used in this way, please contact us on the details below. You can change how you hear from us at any time – contact, or call 020 7618 1720. We collect and process your data to administer our Royal Parks Half Marathon 2022 places and to send you updates. For more information about how we use and protect the information you’re kindly sharing with us, see our privacy policy.

Hospital staff holding sign that says 'Thank you!'
Your're signed up!

Thanks – look in your inbox soon for updates on our work and how your support is making the difference.

Hospital staff holding sign that says 'Thank you!'
Thank you for registering your details, we will get back to you soon.

If you have any queries in the mean time please email: 

Hospital staff holding sign that says 'Thank you!'
Thank you for subscribing!

We’ll send our latest news straight to your inbox each month, keeping you up-to-date with how your support is helping more people across our community and beyond receive extraordinary healthcare. In the meantime you may like to find out how you can get involved to help change lives, or to read our latest news.

Let us know at anytime if you have any questions or would like
more information on our work.

Thanks again for your support – it makes all the difference.

Thank you for your interest in becoming a Barts Charity Champion!

Please enter your details and a member of the team will be in touch soon.

Can we keep in touch?

Sign up here to receive our e-news for staff of the Barts Health Hospitals and Barts and The London School of Medicine and Dentistry. Our fortnightly email will keep you updated on how staff are using our funding to make a difference, as well as ways that you can get involved with fundraising.

You can unsubscribe at any time.

To find out how we look after and use the information that you give us, take a look at our privacy policy.

Hospital staff holding sign that says 'Thank you!'
Thank you for your donation!
From innovative research to day-to-day comforts, you’re helping us to do more for the patients in the hospitals we support. We will email you confirmation of your donation within two working days.
Thank you again.
  • 1
  • 2
  • 3

Your donation

You’re making a single donation of


Where would you like your donation to go?

Is this donation in memory of anyone?

What motivated you to give/fundraise?

We like to share feedback with our NHS colleagues when they have inspired someone.

What did you do to fundraise?

Your details

You are generously donating £5.00

Personal information

We’re currently updating our payment processes; you can make a donation via PayPal or if you wish to make a donation by card please check back in a few days.

Payment details

You are generously donating £5.00

Payment card details

Sign up to our e-news

Our fortnightly email is full of the latest news about the healthcare innovation that we fund, and ways you might want to get involved. You’ll be able to unsubscribe at anytime.

To find out how we look after and use the information you give us, take a look at our privacy policy.

Main form heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.